PIK3CB/p110β is a selective survival factor for glioblastoma

BACKGROUND: Glioblastoma (GBM) is difficult to treat. Phosphoinositide 3-kinase (PI3K) is an attractive therapeutic target for GBM; however, targeting this pathway to effectively treat GBM is not successful because the roles of PI3K isoforms remain to be defined. The aim of this study is to determin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Pridham, Kevin J, Le, Lamvy, Guo, Sujuan, Varghese, Robin T, Algino, Sarah, Liang, Yanping, Fajardin, Renee, Rodgers, Cara M, Simonds, Gary R, Kelly, Deborah F, Sheng, Zhi
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2018
Matèries:
Basic and Translational Investigations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5909664/
https://ncbi.nlm.nih.gov/pubmed/29016844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox181
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars